| abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: there are presented a pharmaceutical composition containing calcipotriene - at least one compound of vitamin D, at least one compound of corticosteroids (betamethasone dipropionate), paraffin, mineral oil, tocopherol and a solvent specified in a list: triglyceride, sorbitan, fatty sorbitan ester, cetearyl glucoside, polyethylene glycol-p-sorbitan stearate, an acrylamide and sodium acryloyldimethyltaurate copolymer, and their mixture, a method for making and applying it for preparing a drug for treating psoriasis. What is shown is the fact that: paraffin provides resistance to anhydrous calcipotriene in the composition with the corticosteroid betamethasone dipropionate. n EFFECT: composition of calcipotriene and betamethasone dipropionate increases the compliance of the patient suffering psoriasis. n 13 cl, 3 tbl, 2 ex |